AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 24 filers reported holding AQUINOX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,930,000 | +18.3% | 279,138 | -1.2% | 0.03% | +26.9% |
| Q4 2017 | $3,323,000 | -17.1% | 282,569 | 0.0% | 0.03% | -13.3% |
| Q3 2017 | $4,010,000 | +2.7% | 282,569 | +1.8% | 0.03% | -9.1% |
| Q2 2017 | $3,905,000 | +60.1% | 277,523 | +89.9% | 0.03% | +65.0% |
| Q1 2017 | $2,439,000 | -46.2% | 146,159 | -46.7% | 0.02% | -45.9% |
| Q4 2016 | $4,530,000 | +24.6% | 274,350 | +0.8% | 0.04% | +8.8% |
| Q3 2016 | $3,636,000 | +365.6% | 272,163 | +130.7% | 0.03% | +385.7% |
| Q2 2016 | $781,000 | -23.4% | 117,970 | +2.1% | 0.01% | -22.2% |
| Q1 2016 | $1,019,000 | -7.2% | 115,574 | +31.3% | 0.01% | -25.0% |
| Q4 2015 | $1,098,000 | -7.6% | 88,005 | +4.3% | 0.01% | -14.3% |
| Q3 2015 | $1,188,000 | -13.0% | 84,416 | -57.1% | 0.01% | +75.0% |
| Q2 2015 | $1,366,000 | +71.6% | 196,738 | +103.3% | 0.01% | -27.3% |
| Q1 2015 | $796,000 | +4.2% | 96,777 | -5.0% | 0.01% | -15.4% |
| Q4 2014 | $764,000 | +8.5% | 101,873 | -3.6% | 0.01% | -7.1% |
| Q3 2014 | $704,000 | -32.5% | 105,646 | -4.5% | 0.01% | -39.1% |
| Q2 2014 | $1,043,000 | -18.3% | 110,643 | +10.3% | 0.02% | -34.3% |
| Q1 2014 | $1,277,000 | – | 100,290 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|